Maravai Lifesciences Holdings, Inc. financial data

Symbol
MRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10770 Wateridge Circle Suite 200, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 982 % +26.5%
Quick Ratio 72.2 % +44.1%
Debt-to-equity 168 % -36.1%
Return On Equity -30.4 % -1212%
Return On Assets -15.9 % -1576%
Operating Margin -73.9 % -466%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 1.37B USD -56.1%
Weighted Average Number of Shares Outstanding, Basic 142M shares +7.3%
Weighted Average Number of Shares Outstanding, Diluted 142M shares +7.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 277M USD -34%
Cost of Revenue 149M USD -11%
Research and Development Expense 19.3M USD +8.8%
Costs and Expenses 482M USD +43.8%
Operating Income (Loss) -205M USD -341%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 441M USD +668%
Income Tax Expense (Benefit) 764M USD
Net Income (Loss) Attributable to Parent -225M USD -1015%
Earnings Per Share, Basic -1.64 USD/shares -1011%
Earnings Per Share, Diluted -1.64 USD/shares -920%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 578M USD -0.25%
Accounts Receivable, after Allowance for Credit Loss, Current 28.9M USD -36.8%
Inventory, Net 50.4M USD +2.58%
Assets, Current 679M USD -3.11%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 163M USD +209%
Operating Lease, Right-of-Use Asset 59.7M USD -6.5%
Intangible Assets, Net (Excluding Goodwill) 202M USD -11.4%
Goodwill 172M USD -47.3%
Other Assets, Noncurrent 60.9M USD -28.8%
Assets 1.28B USD -43.6%
Accounts Payable, Current 4.78M USD -53.9%
Employee-related Liabilities, Current 14.8M USD
Accrued Liabilities, Current 38.5M USD -31.3%
Contract with Customer, Liability, Current 1.83M USD -28.2%
Liabilities, Current 63.2M USD -19.2%
Deferred Income Tax Liabilities, Net 6.69M USD
Operating Lease, Liability, Noncurrent 47.5M USD -7.85%
Other Liabilities, Noncurrent 54.2M USD -16%
Liabilities 665M USD -51.6%
Retained Earnings (Accumulated Deficit) 167M USD -57.4%
Stockholders' Equity Attributable to Parent 345M USD -33.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 613M USD -31.3%
Liabilities and Equity 1.28B USD -43.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.47M USD -110%
Net Cash Provided by (Used in) Financing Activities -560K USD +97.1%
Net Cash Provided by (Used in) Investing Activities -4.24M USD +93.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13.3M USD -243%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 578M USD -0.25%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.1M USD +26.6%
Deferred Tax Assets, Valuation Allowance 642M USD +2601%
Deferred Tax Assets, Gross 642M USD -18.7%
Operating Lease, Liability 54.3M USD -6.11%
Depreciation 19.3M USD +76.8%
Payments to Acquire Property, Plant, and Equipment 5.67M USD -28%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -225M USD -1015%
Lessee, Operating Lease, Liability, to be Paid 73.3M USD -7.39%
Operating Lease, Liability, Current 7.28M USD +2.57%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.4M USD +0.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.2M USD +3.42%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19M USD -10.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10M USD -3.34%
Deferred Tax Assets, Operating Loss Carryforwards 41M USD
Unrecognized Tax Benefits 3.4M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.56M USD -9.46%
Operating Lease, Payments 10.3M USD +46.2%
Additional Paid in Capital 176M USD +40.4%
Amortization of Intangible Assets 6.87M USD +1.54%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 48.2M USD +54.3%
Interest Expense 51.8M USD +27.5%